New hope for stubborn high blood pressure: phase 3 trial launches
Disease control
Not yet recruiting
This study tests a new medicine called TCA108 for people whose high blood pressure is not controlled by current treatments. About 400 adults aged 18 and older will take the drug or a placebo for 10 weeks to see if it safely lowers blood pressure. The goal is to help more people r…
Phase: PHASE3 • Sponsor: EMS • Aim: Disease control
Last updated Jun 15, 2026 19:04 UTC